Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 3
1991 5
1992 1
1993 1
1994 2
1995 4
1996 8
1997 4
1998 3
1999 6
2000 8
2001 4
2002 3
2003 4
2004 5
2005 12
2006 4
2007 6
2008 13
2009 8
2010 15
2011 11
2012 16
2013 13
2014 17
2015 27
2016 22
2017 19
2018 18
2019 19
2020 21
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

288 results
Results by year
Filters applied: . Clear all
Page 1
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
Zeuzem S, Foster GR, Wang S, Asatryan A, Gane E, Feld JJ, Asselah T, BourliĆØre M, Ruane PJ, Wedemeyer H, Pol S, Flisiak R, Poordad F, Chuang WL, Stedman CA, Flamm S, Kwo P, Dore GJ, Sepulveda-Arzola G, Roberts SK, Soto-Malave R, Kaita K, Puoti M, Vierling J, Tam E, Vargas HE, Bruck R, Fuster F, Paik SW, Felizarta F, Kort J, Fu B, Liu R, Ng TI, Pilot-Matias T, Lin CW, Trinh R, Mensa FJ. Zeuzem S, et al. Among authors: flisiak r. N Engl J Med. 2018 Jan 25;378(4):354-369. doi: 10.1056/NEJMoa1702417. N Engl J Med. 2018. PMID: 29365309 Free article. Clinical Trial.
Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study.
Tomasiewicz K, Piekarska A, Stempkowska-Rejek J, Serafińska S, Gawkowska A, Parczewski M, Niścigorska-Olsen J, Łapiński TW, Zarębska-Michaluk D, Kowalska JD, Horban A, Flisiak R. Tomasiewicz K, et al. Among authors: flisiak r. Expert Rev Anti Infect Ther. 2021 Jan;19(1):93-100. doi: 10.1080/14787210.2020.1800453. Epub 2020 Aug 1. Expert Rev Anti Infect Ther. 2021. PMID: 32693650 Free PMC article.
siRNA drug development against hepatitis B virus infection.
Flisiak R, Jaroszewicz J, Łucejko M. Flisiak R, et al. Expert Opin Biol Ther. 2018 Jun;18(6):609-617. doi: 10.1080/14712598.2018.1472231. Epub 2018 May 8. Expert Opin Biol Ther. 2018. PMID: 29718723 Review.
Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study.
Flisiak R, Zarębska-Michaluk D, Berkan-Kawińska A, Tudrujek-Zdunek M, Rogalska M, Piekarska A, Kozielewicz D, Kłos K, Rorat M, Bolewska B, Szymanek-Pasternak A, Mazur W, Lorenc B, Podlasin R, Sikorska K, Oczko-Grzesik B, Iwaszkiewicz C, Szetela B, Pabjan P, Pawłowska M, Tomasiewicz K, Polańska J, Jaroszewicz J. Flisiak R, et al. Pol Arch Intern Med. 2021 Jan 29;131(1):103-110. doi: 10.20452/pamw.15735. Epub 2020 Dec 31. Pol Arch Intern Med. 2021. PMID: 33382547 Free article. No abstract available.
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020.
Flisiak R, Horban A, Jaroszewicz J, Kozielewicz D, Pawłowska M, Parczewski M, Piekarska A, Simon K, Tomasiewicz K, Zarębska-Michaluk D. Flisiak R, et al. Pol Arch Intern Med. 2020 Apr 30;130(4):352-357. doi: 10.20452/pamw.15270. Epub 2020 Mar 31. Pol Arch Intern Med. 2020. PMID: 32231173 Free article. Updated. No abstract available.
Combination of Tenofovir Disoproxil Fumarate and Peginterferon Ī±-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.
Marcellin P, Ahn SH, Ma X, Caruntu FA, Tak WY, Elkashab M, Chuang WL, Lim SG, Tabak F, Mehta R, Petersen J, Foster GR, Lou L, Martins EB, Dinh P, Lin L, Corsa A, Charuworn P, Subramanian GM, Reiser H, Reesink HW, Fung S, Strasser SI, Trinh H, Buti M, Gaeta GB, Hui AJ, Papatheodoridis G, Flisiak R, Chan HL; Study 149 Investigators. Marcellin P, et al. Among authors: flisiak r. Gastroenterology. 2016 Jan;150(1):134-144.e10. doi: 10.1053/j.gastro.2015.09.043. Epub 2015 Oct 8. Gastroenterology. 2016. PMID: 26453773 Free article. Clinical Trial.
Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk.
Jarcuska P, Abdel-Razik A, Flisiak R, Singh RB. Jarcuska P, et al. Among authors: flisiak r. Can J Gastroenterol Hepatol. 2018 Nov 4;2018:7369314. doi: 10.1155/2018/7369314. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30519548 Free PMC article. No abstract available.
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N; Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group. Lau GK, et al. Among authors: flisiak r. N Engl J Med. 2005 Jun 30;352(26):2682-95. doi: 10.1056/NEJMoa043470. N Engl J Med. 2005. PMID: 15987917 Free article. Clinical Trial.
Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study.
Brouwer WP, Chan HLY, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong VW, Soffredini R, Liang X, Chen S, Groothuismink ZMA, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen HLA; GIANT-B Global Consortium. Brouwer WP, et al. Among authors: flisiak r. Clin Infect Dis. 2019 Nov 13;69(11):1969-1979. doi: 10.1093/cid/ciz084. Clin Infect Dis. 2019. PMID: 30715261 Free PMC article.
288 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page